TriSalus Life Sciences, Inc. - TLSI
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2026 | CEO and President | P | A | 34,328.0 | 2.59 | 88,909.52 | 1,140,182.0 | View | |
| Nov 19, 2026 | CEO and President | P | A | 30,864.0 | 2.31 | 71,295.84 | 1,105,854.0 | View | |
| Nov 19, 2026 | — | P | A | 10,000.0 | 2.2 | 22,000.0 | 82,510.0 | View | |
| Nov 17, 2026 | Chief Commercial Officer | S | D | 544.0 | 2.43 | 1,321.92 | 127,450.0 | View | |
| Nov 16, 2026 | — | P | A | 50,000.0 | 2.24 | 112,000.0 | 197,555.0 | View | |
| Oct 07, 2026 | Chief of Research | S | D | 296.0 | 4.39 | 1,299.44 | 162,805.0 | View | |
| Oct 07, 2026 | Chief Commercial Officer | S | D | 325.0 | 4.39 | 1,426.75 | 127,994.0 | View | |
| Oct 07, 2026 | Chief Regulatory Officer | S | D | 316.0 | 4.39 | 1,387.24 | 123,794.0 | View | |
| Oct 07, 2026 | CEO and President | F | D | 2,693.0 | 4.38 | 11,795.34 | 1,074,990.0 | View | |
| Jul 06, 2026 | Chief Financial Officer | F | D | 14,650.0 | 4.46 | 65,339.0 | 261,107.0 | View | |
| Jul 01, 2026 | CEO and President | A | A | 3,990.0 | 3.87 | 15,441.3 | 1,077,683.0 | View | |
| Jul 01, 2026 | Chief Commercial Officer | A | A | 561.0 | 3.87 | 2,171.07 | 128,319.0 | View | |
| Jun 29, 2026 | Chief Medical Officer | A | A | 120,000.0 | 0.0 | 0.0 | 253,000.0 | View | |
| Jun 29, 2026 | Chief Medical Officer | A | A | 60,000.0 | 0.0 | 0.0 | 90,000.0 | View |